Skip to content

OCULUS INC.: 10-Q filed 2019-11-14

What OCULUS INC. reported in its quarterly report filed 2019-11-14 (fiscal Q3 2019): 15 published measures, 36 facts as tagged in accession 0001437749-19-022836.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-14
Fiscal period
fiscal Q3 2019
Accession
0001437749-19-022836 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OCULUS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-30413,623USD
At 2018-12-316,764USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-30276,185USD
At 2018-12-31-735,534USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-30412,892USD
At 2018-12-315,572USD
At 2018-09-30594USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-42,817USD92
2019-01-01 to 2019-09-30-164,983USD273
2018-01-01 to 2018-12-31-183,279USD365
2018-07-01 to 2018-09-30-25,984USD92
2018-01-01 to 2018-09-30-91,669USD273
2017-01-01 to 2017-12-31-230,699USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-769,382USD273
2018-01-01 to 2018-09-30594USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-301,176,702USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-41,358,814USD
At 2018-12-31-41,193,831USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-43,098USD92
2019-01-01 to 2019-09-30-165,264USD273
2018-07-01 to 2018-09-30-25,984USD92
2018-01-01 to 2018-09-30-91,669USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-30413,623USD
At 2018-12-316,764USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-30137,438USD
At 2018-12-31742,298USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-07-01 to 2019-09-3043,098USD92
2019-01-01 to 2019-09-30165,264USD273
2018-07-01 to 2018-09-3025,984USD92
2018-01-01 to 2018-09-3089,850USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-01-01 to 2018-09-301,819USD273

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-09-30731USD
At 2018-12-311,192USD

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-07-01 to 2019-09-30281USD92
2019-01-01 to 2019-09-30281USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-01-01 to 2019-09-301,176,702USD273

Inspect the source

Entity
OCULUS INC. / CIK 0001107280
Captured
2026-09-20T05:23:31.283Z
SEC response SHA-256
63097be359140327b7dc122e8108372f9ed2c94e74a857e52ba6271b22125468

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001107280.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))